ALTEVAX
Altevax is developing and will bring to market an entirely new vaccine technology for cancer and infectious diseases. This patented technology, which consists in a melanin-based adjuvant embedding an antigen, has shown superior efficacy in treating tumours relative to existing methods. In multiple lab tests, the technology was proven to trigger a very powerful immune response against cancers and viruses, demonstrating dramatically superior effectiveness relative to current cancer vaccines benchm... arks. The Altevax technology triggers antigen-specific Cytotoxic T-lymphocytes (CTLs), the organism's most effective defenders. These antigen-specific CTLs destroy the cancerous cells while leaving heathy cells intact. Melanin is a non-toxic compound, naturally present compound in the human body and responsible for the skin's colour. Unlike other vaccines in the market or under development today that present significant toxicity issues, the Altevax technology is therefore likely to have no or very limited toxic effect.
ALTEVAX
Social Links:
Industry:
Biotechnology
Founded:
2016-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.altevax.com
Total Employee:
1+
Status:
Active
Contact:
+33 9 70 40 54 00
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Content Delivery Network SSL By Default HSTS Microsoft Exchange Online Office 365 Mail
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Investors List
AGORANOV
AGORANOV investment in Venture Round - Altevax
Official Site Inspections
http://www.altevax.com Semrush global rank: 13.98 M Semrush visits lastest month: 67
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Altevax"
Altevax | A first-in-class immunotherapy against cancer
Altevax is committed to bringing its innovative anticancer and anti-infectious technology to patients, to treat diseases that have no available cure today. Using melanin as an adjuvant, โฆSee details»
Altevax - Crunchbase Company Profile & Funding
Altevax is developing and will bring to market an entirely new vaccine technology for cancer and infectious diseases. This patented technology, which consists โฆSee details»
Altevax 2025 Company Profile: Valuation, Funding
Altevax General Information Description. Developer of a therapeutic vaccine intended for breakthrough immunotherapy technology, using a melanin-based โฆSee details»
Altevax Biotech - LinkedIn
Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific ...See details»
Altevax | Paris, France Startup
Altevax' pioneering immunotherapy relies on a melanin-based vaccine adjuvant, which has been proven in pre-clinical trials. This technology triggers an immune response with CD8+ T cells, โฆSee details»
Altevax - Contacts, Employees, Board Members, Advisors & Alumni
Altevax is developing a technology in cancer vaccines. Start Free Trial . Chrome ExtensionSee details»
Altevax Company Profile - Office Locations, Competitors ... - Craft
Altevax is a company that develops and markets a vaccine technology for cancer and infectious diseases. Its technology triggers antigen-specific Cytotoxic T-lymphocytes (CTLs), the โฆSee details»
Altevax - Funding, Financials, Valuation & Investors - Crunchbase
Jul 1, 2016 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 1, 2016: โฆSee details»
Altevax - VentureRadar
The Altevax therapeutic vaccines work particularly well with short peptides, making this technology a precursor to personalised anti-cancer vaccines. The Altevax technology is โฆSee details»
Altevax - Drug pipelines, Patents, Clinical trials - Synapse
Explore Altevax with its drug pipeline, therapeutic area, technology platform, .See details»
ALTEVAX SAS - France Biotech
ALTEVAX développe une plateforme dโimmunothérapie innovante et disruptive pour le traitement du cancer. Elle est basée sur la mélanine synthétique, un adjuvant biopolymère non toxique et โฆSee details»
Altevax | BIO-Europe Spring - informaconnect.com
BIO-Europe Spring is the premier springtime partnering conference bringing together a โwhoสผs whoโ from biotech, pharma and finance in the most innovative biopharma clusters in Europe โฆSee details»
I-Démo news | Altevax
ALTEVAX aims to bring MELITECH to the clinic in 2024. Paris, France, March 2023 โ ALTEVAX Bioscience, a French biotech company that is harnessing the properties synthetic melanin, โฆSee details»
ALTEVAX
ALTEVAX is a preclinical biotech firm creating a groundbreaking immunotherapy platform using synthetic Melanin and versatile peptides for cancer treatment. With proven efficacy in animal โฆSee details»
Top Altevax companies - VentureRadar
Altevax. n/a. Founded 2016. France. Altevax is developing a powerful pioneering technology in cancer and anti-viral vaccines. Its patent-pending, melanin-based technology, which has been โฆSee details»
Altevax | VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, โฆSee details»
ALTEVAX - Viva Technology
ALTEVAX lead program, a therapeutic vaccine against Glioblastoma, is based on the tumor-associated antigen TERT (from the telomerase complex). This tumor antigen has been โฆSee details»
Altevax: la biotech contre le cancer - Challenges
Altevax s'attelle à trouver une solution thérapeutique contre tous les types de cancer. Cette start-up fait partie de la sélection "100 start-up où investir en 2020โ de Challenges.See details»
Vaccines, innovation and lโX ecosystem - École polytechnique
Jan 21, 2021 Altevax has developed an immunotherapy treatment based on a patent filed by Professor Antoine Carpentier of the Saint-Louis Hospital (Paris) on the power of melanin to โฆSee details»
Startup ALTEVAX Développe une immunothérapie active โฆ
Altevax développe une puissante technologie pionnière dans le domaine des vaccins anticancéreux et antiviraux. Sa technologie à base de mélanine en instance de brevet, qui a โฆSee details»